Table 1 Licensed products for passive immunization of ruminants, horses and pigs.
Product type | Animal | Disease prevention/targeted pathogens | Immunoglobulin type/origin | Administration (oral/parenteral) |
|---|---|---|---|---|
E. coli specific antibodies | Calves | Scour | Bovine colostrum IgG/IgY | Oral |
Antibacterial bovine serum antibodies | Cattle | Arcanobacterium pyogenes | Bovine serum | Parenteral |
Calves | E. coli | Â | Â | |
Sheep | Mannheimia haemolytica Pasteurella multocida Salmonella typhimurium | Â | Â | |
Clostridial antitoxins | Cattle | Clostridium perfringens | Equine Ig | Parenteral (sc and iv) |
Calves | C&D | Â | Â | |
Goats | Clostridium botulinum | Â | Â | |
Sheep | C&B | Â | Â | |
Swine | Â | Â | Â | |
Horses | Â | Â | Â | |
Tetanus antitoxin | Horses | Tetanus | Equine serum | Parenteral |
Cattle | Â | Â | Â | |
Sheep | Â | Â | Â | |
Swine | Â | Â | Â | |
Goats | Â | Â | Â | |
Anti-West Nile virus antibodies | Horses | West Nile virus | Equine Ig | Parenteral |
Anti-endotoxin antibodies | Horses | Septicaemia | Equine plasma from hyper-immune horses | Parenteral |
Antibacterial plasma antibodies | Horses | Rhodococcus equi E. coli J-5 | Equine plasma from hyper-immune horses | Parenteral |
Equine plasma | Horses | Failure of passive transfer | Equine plasma | Â |